Literature DB >> 24753526

Hemostatic abnormalities in Noonan syndrome.

Andrea Artoni1, Angelo Selicorni2, Serena M Passamonti1, Anna Lecchi1, Paolo Bucciarelli1, Marta Cerutti3, Paola Cianci2, Francesca Gianniello1, Ida Martinelli4.   

Abstract

BACKGROUND: A bleeding diathesis is a common feature of Noonan syndrome, and various coagulation abnormalities have been reported. Platelet function has never been carefully investigated.
METHODS: The degree of bleeding diathesis in a cohort of patients with Noonan syndrome was evaluated by a validated bleeding score and investigated with coagulation and platelet function tests. If ratios of prothrombin time and/or activated partial thromboplastin time were prolonged, the activity of clotting factors was measured. Individuals with no history of bleeding formed the control group.
RESULTS: The study population included 39 patients and 28 controls. Bleeding score was ≥2 (ie, suggestive of a moderate bleeding diathesis) in 15 patients (38.5%) and ≥4 (ie, suggestive of a severe bleeding diathesis) in 7 (17.9%). Abnormal coagulation and/or platelet function tests were found in 14 patients with bleeding score ≥2 (93.3%) but also in 21 (87.5%) of those with bleeding score <2. The prothrombin time and activated partial thromboplastin time were prolonged in 18 patients (46%) and partial deficiency of factor VII, alone or in combination with the deficiency of other vitamin K-dependent factors, was the most frequent coagulation abnormality. Moreover, platelet aggregation and secretion were reduced in 29 of 35 patients (82.9%, P < .01 for all aggregating agents).
CONCLUSIONS: Nearly 40% of patients with the Noonan syndrome had a bleeding diathesis and >90% of them had platelet function and/or coagulation abnormalities. Results of these tests should be taken into account in the management of bleeding or invasive procedures in these patients.
Copyright © 2014 by the American Academy of Pediatrics.

Entities:  

Keywords:  Noonan syndrome; bleeding score; coagulation; platelets

Mesh:

Year:  2014        PMID: 24753526     DOI: 10.1542/peds.2013-3251

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  8 in total

Review 1.  CHD associated with syndromic diagnoses: peri-operative risk factors and early outcomes.

Authors:  Benjamin J Landis; David S Cooper; Robert B Hinton
Journal:  Cardiol Young       Date:  2015-09-08       Impact factor: 1.093

2.  Congenital heart defects in Noonan syndrome: Diagnosis, management, and treatment.

Authors:  Léa Linglart; Bruce D Gelb
Journal:  Am J Med Genet C Semin Med Genet       Date:  2020-02-05       Impact factor: 3.908

3.  Sequential Loss of Mandibular Permanent Incisors in Noonan Syndrome.

Authors:  Reinhard E Friedrich; Hanna A Scheuer
Journal:  In Vivo       Date:  2022 Mar-Apr       Impact factor: 2.155

4.  DRESS syndrome with thrombotic microangiopathy revealing a Noonan syndrome: Case report.

Authors:  Mickaël Bobot; Matteo Coen; Clémentine Simon; Laurent Daniel; Gilbert Habib; Jacques Serratrice
Journal:  Medicine (Baltimore)       Date:  2018-04       Impact factor: 1.889

5.  Evaluation of bleeding disorders in patients with Noonan syndrome: a systematic review.

Authors:  Diane J Nugent; Alicia A Romano; Shreya Sabharwal; David L Cooper
Journal:  J Blood Med       Date:  2018-10-23

6.  RASopathies and hemostatic abnormalities: key role of platelet dysfunction.

Authors:  Francesca Di Candia; Valeria Marchetti; Ferdinando Cirillo; Alessandro Di Minno; Carmen Rosano; Stefano Pagano; Maria Anna Siano; Mariateresa Falco; Antonia Assunto; Giovanni Boccia; Gerardo Magliacane; Valentina Pinna; Alessandro De Luca; Marco Tartaglia; Giovanni Di Minno; Pietro Strisciuglio; Daniela Melis
Journal:  Orphanet J Rare Dis       Date:  2021-12-02       Impact factor: 4.123

Review 7.  A new horizon of moyamoya disease and associated health risks explored through RNF213.

Authors:  Akio Koizumi; Hatasu Kobayashi; Toshiaki Hitomi; Kouji H Harada; Toshiyuki Habu; Shohab Youssefian
Journal:  Environ Health Prev Med       Date:  2015-12-10       Impact factor: 3.674

Review 8.  Small GTPases in platelet membrane trafficking.

Authors:  Tony G Walsh; Yong Li; Andreas Wersäll; Alastair W Poole
Journal:  Platelets       Date:  2018-10-26       Impact factor: 3.862

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.